STOCK TITAN

Babcock & Wilcox Enterprises I Financials

BW
Trailing 12 months to June 30, 2026
Revenue $834.4M +50.9% YoY
Net Income -$15.0M +90.7% YoY
EPS (Diluted) -$0.14 YoY not available
Free Cash Flow -$58.2M +57.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Babcock & Wilcox Enterprises I (BW) reported $834.4M in revenue over the twelve months to Jun 30, 2026, up 50.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BW FY2025

Operating recovery is emerging, but the business still depends on non-operating cash while liabilities exceed assets.

FY2025’s operating income of $20.7M coexisted with operating cash flow of -$68.9M, so accounting improvement did not become cash. Accounts receivable rose from $91.8M in FY2024 to $118.4M in FY2025 while free cash flow remained negative, pointing to working-capital absorption as a key pressure on cash conversion.

Gross margin rebounded to 24.5% in FY2025 from 21.8% in FY2024, a margin-shape improvement without meaningful top-line expansion. With SG&A at $119M and operating margin at 3.5%, the turnaround appears tied more to cost discipline or mix than volume growth.

Liabilities exceeded assets by $132M in FY2025, leaving negative equity even after operating income turned positive. The current ratio narrowed to 1.2x from 2.3x in FY2021, showing thinner short-term flexibility despite improved reported operating results.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 22 / 100
Financial Health Score 22/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Babcock & Wilcox Enterprises I's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
26

Babcock & Wilcox Enterprises I has an operating margin of 3.5%, meaning the company retains $4 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is up from -1.1% the prior year.

Growth
32

Babcock & Wilcox Enterprises I's revenue grew a modest 1.1% year-over-year to $587.7M. This slow but positive growth earns a score of 32/100.

Leverage
1
Liquidity
29

Babcock & Wilcox Enterprises I's current ratio of 1.22 is below the typical benchmark, resulting in a score of 29/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
13

Babcock & Wilcox Enterprises I's operations used $68.9M of cash, and capex of $16.8M added to the outflow, for a free cash flow shortfall of $85.7M. This results in a cash flow score of 13/100.

Returns
31
Altman Z-Score Distress
-1.64

Babcock & Wilcox Enterprises I scores -1.64, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.1B) relative to total liabilities ($794.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Babcock & Wilcox Enterprises I passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Babcock & Wilcox Enterprises I reported a net loss of $32.8M while operations used $68.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage Adequate
4.61x

Babcock & Wilcox Enterprises I earns $4.61 in operating income for every $1 of interest expense ($20.7M vs $4.5M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$587.7M
YoY+1.1%
5Y CAGR+0.7%
10Y CAGR-10.4%

Babcock & Wilcox Enterprises I generated $587.7M in revenue in fiscal year 2025. This represents an increase of 1.1% from the prior year.

EBITDA
$30.9M
YoY+197.6%
5Y CAGR+15.4%
10Y CAGR-5.9%

Babcock & Wilcox Enterprises I's EBITDA was $30.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 197.6% from the prior year.

Net Income
-$32.8M
YoY+55.0%

Babcock & Wilcox Enterprises I reported -$32.8M in net income in fiscal year 2025. This represents an increase of 55.0% from the prior year.

EPS (Diluted)
-$0.48
YoY+41.5%

Babcock & Wilcox Enterprises I earned -$0.48 per diluted share (EPS) in fiscal year 2025. This represents an increase of 41.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$85.7M
YoY+34.1%

Babcock & Wilcox Enterprises I recorded an outflow of $85.7M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 34.1% from the prior year.

Cash & Debt
$89.5M
YoY+233.1%
5Y CAGR+9.3%
10Y CAGR-13.1%

Babcock & Wilcox Enterprises I held $89.5M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
135M
YoY+37.4%

Babcock & Wilcox Enterprises I had 135M shares outstanding in fiscal year 2025. This represents an increase of 37.4% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
24.5%
YoY+2.7pp
5Y CAGR-74.8pp
10Y CAGR+6.9pp

Babcock & Wilcox Enterprises I's gross margin was 24.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.7 percentage points from the prior year.

Operating Margin
3.5%
YoY+4.6pp
5Y CAGR+3.8pp
10Y CAGR+2.3pp

Babcock & Wilcox Enterprises I's operating margin was 3.5% in fiscal year 2025, reflecting core business profitability. This is up 4.6 percentage points from the prior year.

Net Margin
-5.6%
YoY+7.0pp
5Y CAGR-3.8pp
10Y CAGR-6.7pp

Babcock & Wilcox Enterprises I's net profit margin was -5.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.0 percentage points from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$386K
YoY+14.9%
5Y CAGR+6.4%
10Y CAGR-34.2%

Babcock & Wilcox Enterprises I spent $386K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 14.9% from the prior year.

Capital Expenditures
$16.8M
YoY+49.7%
5Y CAGR+15.3%
10Y CAGR-7.2%

Babcock & Wilcox Enterprises I invested $16.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 49.7% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

BW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BW quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$319.7M+49.1%$214.4M+41.8%$151.2M+1.5%$149.0M+7.3%$138.9M-6.6%$148.6M+31.8%$112.7M-26.2%$152.6M
Cost of Revenue$273.1M+59.7%$171.0M+50.3%$113.7M+1.7%$111.9M+14.9%$97.4M-19.4%$120.8M+28.6%$93.9M-19.4%$116.5M
Gross Profit$46.6M+7.3%$43.5M+15.9%$37.5M+0.9%$37.1M-10.4%$41.5M+49.3%$27.8M+47.9%$18.8M-48.0%$36.1M
SG&A Expenses$33.7M-24.1%$44.4M+58.1%$28.1M-5.8%$29.8M-10.7%$33.3M+17.8%$28.3M+26.6%$22.4M-32.9%$33.3M
Operating Income$11.8M+810.7%-$1.7M-118.3%$9.1M+39.4%$6.5M-7.4%$7.0M+480.7%-$1.8M+79.9%-$9.2M-685.6%$1.6M
Interest Expense$1.0M-28.0%$1.4M+5.1%$1.3M+2.2%$1.3M-6.4%$1.4M+209.5%$452K-98.6%$31.6M+8088.1%$386K
Income Tax-$1.1M-125.9%$4.2M+217.8%$1.3M+27.1%$1.0M-74.4%$4.0M+109.3%$1.9M-75.1%$7.7M+1620.5%-$508K
Net Income$14.3M+118.5%-$76.9M-710.3%$12.6M-64.1%$35.1M+160.0%-$58.5M-165.8%-$22.0M+71.1%-$76.1M-1328.0%-$5.3M
EPS (Diluted)$0.07-$0.60-766.7%$0.09-70.0%$0.30+147.6%-$0.63-142.3%-$0.26+64.4%-$0.73-$0.10

Not reported in any period shown, so not listed: R&D Expenses.

BW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BW quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$999.6M+31.9%$757.8M+14.3%$662.9M+0.8%$657.9M-6.5%$703.5M-2.3%$719.7M-1.0%$727.0M-9.6%$804.6M
Current Assets$725.4M+47.7%$491.3M+4.4%$470.7M-1.9%$479.7M-9.0%$526.9M+9.1%$482.9M-12.8%$553.5M+4.4%$530.2M
Cash & Equivalents$308.6M+189.7%$106.5M+19.1%$89.5M+254.7%$25.2M+7.6%$23.4M-0.3%$23.5M-12.5%$26.9M-12.3%$30.6M
Inventory$61.0M+0.4%$60.7M-0.2%$60.9M-5.7%$64.6M-1.7%$65.7M-41.1%$111.5M+91.2%$58.3M-50.0%$116.6M
Accounts Receivable$170.7M+35.1%$126.4M+6.7%$118.4M+16.4%$101.7M+4.9%$96.9M-7.9%$105.2M+14.6%$91.8M+1.9%$90.0M
Goodwill$52.1M-1.1%$52.7M-0.8%$53.1M+1.0%$52.6M-1.6%$53.4M-35.2%$82.5M+60.5%$51.4M-39.2%$84.6M
Total Liabilities$942.2M+1.3%$929.9M+17.1%$794.5M-10.7%$890.1M-12.1%$1.0B-1.0%$1.0B+1.2%$1.0B+0.2%$1.0B
Current Liabilities$500.3M+1.2%$494.5M+27.9%$386.7M-3.6%$401.0M-24.2%$529.3M+3.5%$511.2M+25.7%$406.7M+36.5%$297.9M
Total Equity$57.4M+133.3%-$172.1M-30.8%-$131.5M+43.4%-$232.2M+24.9%-$309.2M-2.1%-$303.0M-6.8%-$283.8M-39.3%-$203.7M
Retained Earnings-$1.8B+0.6%-$1.8B-4.8%-$1.7B+0.3%-$1.7B+1.8%-$1.7B-3.7%-$1.7B-1.6%-$1.6B-4.2%-$1.6B

Not reported in any period shown, so not listed: Long-Term Debt.

BW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BW quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$17.4M-197.9%$17.8M+694.9%-$3.0M+90.7%-$32.1M-26.9%-$25.3M-198.6%-$8.5M+62.4%-$22.5M+67.6%-$69.5M
Capital Expenditures$6.6M-7.1%$7.1M+70.7%$4.2M-24.3%$5.5M+100.8%$2.7M-36.5%$4.3M+301.5%$1.1M-50.0%$2.2M
Free Cash Flow-$24.0M-325.4%$10.7M+248.8%-$7.2M+81.0%-$37.6M-34.1%-$28.1M-119.1%-$12.8M+45.7%-$23.6M+67.1%-$71.6M
Investing Cash Flow-$6.3M-78.8%-$3.5M-114.4%$24.6M-84.8%$161.8M+1011.4%$14.6M+472.6%-$3.9M-112.2%$32.0M+1561.3%$1.9M
Financing Cash Flow$211.7M+1142.5%-$20.3M+4.9%-$21.4M+46.6%-$40.0M-1434.5%$3.0M+823.2%-$414K+62.6%-$1.1M+89.7%-$10.8M
Share BuybacksN/AN/A$0-100.0%$386KN/AN/A$62K-76.0%$258K

Not reported in any period shown, so not listed: Dividends Paid.

BW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

BW quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin14.6%-5.7pp20.3%-4.5pp24.8%-0.1pp24.9%-4.9pp29.8%+11.2pp18.7%+2.0pp16.7%-7.0pp23.7%
Operating Margin3.7%+4.5pp-0.8%-6.8pp6.0%+1.6pp4.4%-0.7pp5.1%+6.3pp-1.2%+6.9pp-8.1%-9.2pp1.0%
Net Margin4.5%+40.3pp-35.9%-44.2pp8.3%-15.2pp23.5%+65.7pp-42.1%-27.3pp-14.8%+52.8pp-67.6%-64.1pp-3.5%
Return on Equity24.9%N/AN/AN/AN/AN/AN/AN/A
Return on Assets1.4%+11.6pp-10.2%-12.1pp1.9%-3.4pp5.3%+13.6pp-8.3%-5.2pp-3.1%+7.4pp-10.5%-9.8pp-0.7%
Current Ratio1.45+0.5x0.99-0.2x1.220.0x1.20+0.2x1.00+0.1x0.94-0.4x1.36-0.4x1.78
Debt-to-Equity16.42N/AN/AN/AN/AN/AN/AN/A
FCF Margin-7.5%-12.5pp5.0%+9.7pp-4.7%+20.5pp-25.3%-5.0pp-20.2%-11.6pp-8.6%+12.3pp-20.9%+26.0pp-46.9%

Note: Shareholder equity is negative (-$131.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

What is Babcock & Wilcox Enterprises I's annual revenue?

Babcock & Wilcox Enterprises I (BW) reported $587.7M in total revenue for fiscal year 2025. This represents a 1.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Babcock & Wilcox Enterprises I's revenue growing?

Babcock & Wilcox Enterprises I (BW) revenue grew by 1.1% year-over-year, from $581.0M to $587.7M in fiscal year 2025.

Is Babcock & Wilcox Enterprises I profitable?

No, Babcock & Wilcox Enterprises I (BW) reported a net income of -$32.8M in fiscal year 2025, with a net profit margin of -5.6%.

Babcock & Wilcox Enterprises I (BW) reported diluted earnings per share of -$0.48 for fiscal year 2025. This represents a 41.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Babcock & Wilcox Enterprises I (BW) had EBITDA of $30.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Babcock & Wilcox Enterprises I (BW) had a gross margin of 24.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Babcock & Wilcox Enterprises I (BW) had an operating margin of 3.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Babcock & Wilcox Enterprises I (BW) had a net profit margin of -5.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Babcock & Wilcox Enterprises I (BW) recorded an outflow of $85.7M in free cash flow during fiscal year 2025. This represents a 34.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Babcock & Wilcox Enterprises I (BW) recorded an outflow of $68.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Babcock & Wilcox Enterprises I (BW) had $662.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Babcock & Wilcox Enterprises I (BW) invested $16.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Babcock & Wilcox Enterprises I (BW) spent $386K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Babcock & Wilcox Enterprises I (BW) had 135M shares outstanding as of fiscal year 2025.

Babcock & Wilcox Enterprises I (BW) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.

Babcock & Wilcox Enterprises I (BW) had a return on assets of -5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Babcock & Wilcox Enterprises I (BW) held $96.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $68.9M over that year. Dividing the one by the other, the reported balance equals about 17 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Babcock & Wilcox Enterprises I (BW) has negative shareholder equity of -$131.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Babcock & Wilcox Enterprises I (BW) has an Altman Z-Score of -1.64, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Babcock & Wilcox Enterprises I (BW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Babcock & Wilcox Enterprises I (BW) reported a net loss of $32.8M while operations used $68.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Babcock & Wilcox Enterprises I (BW) has an interest coverage ratio of 4.61x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Babcock & Wilcox Enterprises I (BW) scores 22 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top